Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 64 | 2024 | 754 | 15.260 |
Why?
|
| Quality of Life | 50 | 2023 | 964 | 8.990 |
Why?
|
| Spirituality | 16 | 2024 | 38 | 4.970 |
Why?
|
| Adaptation, Psychological | 22 | 2022 | 131 | 3.500 |
Why?
|
| Young Adult | 55 | 2024 | 2649 | 3.130 |
Why?
|
| Psychometrics | 15 | 2022 | 137 | 2.800 |
Why?
|
| Adolescent | 52 | 2024 | 3519 | 2.670 |
Why?
|
| Religion and Medicine | 6 | 2016 | 18 | 2.390 |
Why?
|
| Survivors | 17 | 2023 | 173 | 2.360 |
Why?
|
| Stress, Psychological | 16 | 2024 | 217 | 2.230 |
Why?
|
| Humans | 96 | 2024 | 32284 | 1.920 |
Why?
|
| Self Efficacy | 4 | 2019 | 74 | 1.800 |
Why?
|
| Social Support | 9 | 2024 | 180 | 1.780 |
Why?
|
| Resilience, Psychological | 3 | 2024 | 20 | 1.760 |
Why?
|
| Adult | 52 | 2024 | 9259 | 1.750 |
Why?
|
| Female | 62 | 2024 | 19947 | 1.340 |
Why?
|
| Health Status | 6 | 2018 | 355 | 1.300 |
Why?
|
| Male | 51 | 2024 | 19443 | 1.270 |
Why?
|
| Mental Health | 7 | 2023 | 111 | 1.240 |
Why?
|
| Caregivers | 4 | 2024 | 114 | 1.220 |
Why?
|
| Medical Oncology | 4 | 2023 | 90 | 1.180 |
Why?
|
| National Institutes of Health (U.S.) | 6 | 2018 | 31 | 1.150 |
Why?
|
| Emotions | 6 | 2024 | 54 | 1.050 |
Why?
|
| Personal Satisfaction | 5 | 2018 | 28 | 0.900 |
Why?
|
| Telemedicine | 2 | 2023 | 122 | 0.850 |
Why?
|
| Patients | 2 | 2016 | 46 | 0.840 |
Why?
|
| Middle Aged | 30 | 2020 | 11853 | 0.840 |
Why?
|
| Chronic Disease | 6 | 2023 | 413 | 0.800 |
Why?
|
| Reproducibility of Results | 10 | 2022 | 757 | 0.770 |
Why?
|
| Fatigue | 5 | 2019 | 76 | 0.760 |
Why?
|
| Psychology | 3 | 2019 | 25 | 0.730 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 312 | 0.670 |
Why?
|
| Biomedical Research | 2 | 2024 | 178 | 0.620 |
Why?
|
| Colorectal Neoplasms | 3 | 2014 | 219 | 0.600 |
Why?
|
| United States | 15 | 2024 | 4072 | 0.600 |
Why?
|
| Cognition | 6 | 2015 | 547 | 0.580 |
Why?
|
| Income | 1 | 2019 | 66 | 0.560 |
Why?
|
| Aged | 19 | 2023 | 10265 | 0.510 |
Why?
|
| Depression | 6 | 2024 | 420 | 0.510 |
Why?
|
| Affective Symptoms | 2 | 2015 | 15 | 0.500 |
Why?
|
| Grief | 1 | 2016 | 1 | 0.500 |
Why?
|
| Attitude to Death | 1 | 2016 | 2 | 0.500 |
Why?
|
| Antineoplastic Agents | 4 | 2023 | 595 | 0.500 |
Why?
|
| Bereavement | 1 | 2016 | 4 | 0.490 |
Why?
|
| Infertility | 1 | 2016 | 15 | 0.470 |
Why?
|
| Religion and Psychology | 3 | 2016 | 5 | 0.460 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 1479 | 0.450 |
Why?
|
| Guideline Adherence | 1 | 2016 | 109 | 0.450 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 83 | 0.440 |
Why?
|
| Continental Population Groups | 1 | 2016 | 228 | 0.440 |
Why?
|
| Anorexia | 1 | 2014 | 6 | 0.440 |
Why?
|
| Cachexia | 1 | 2014 | 7 | 0.440 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 3902 | 0.430 |
Why?
|
| Health Status Indicators | 1 | 2014 | 69 | 0.420 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2022 | 541 | 0.420 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 245 | 0.410 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 395 | 0.410 |
Why?
|
| Ethnic Groups | 1 | 2016 | 450 | 0.410 |
Why?
|
| Factor Analysis, Statistical | 6 | 2019 | 76 | 0.410 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 108 | 0.400 |
Why?
|
| Vomiting | 2 | 2014 | 19 | 0.390 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2014 | 42 | 0.380 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2024 | 158 | 0.380 |
Why?
|
| Nausea | 2 | 2014 | 49 | 0.380 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 46 | 0.380 |
Why?
|
| Survival Rate | 5 | 2019 | 893 | 0.370 |
Why?
|
| Research Design | 3 | 2023 | 314 | 0.370 |
Why?
|
| Social Isolation | 3 | 2024 | 41 | 0.340 |
Why?
|
| Perception | 1 | 2012 | 99 | 0.340 |
Why?
|
| Health Personnel | 1 | 2012 | 112 | 0.330 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 423 | 0.330 |
Why?
|
| Ovarian Neoplasms | 3 | 2006 | 84 | 0.310 |
Why?
|
| Socioeconomic Factors | 5 | 2023 | 388 | 0.300 |
Why?
|
| Mental Health Services | 3 | 2024 | 34 | 0.300 |
Why?
|
| Child | 7 | 2023 | 2435 | 0.300 |
Why?
|
| Feasibility Studies | 4 | 2023 | 308 | 0.290 |
Why?
|
| Self Concept | 2 | 2023 | 45 | 0.280 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 762 | 0.280 |
Why?
|
| Mass Screening | 3 | 2006 | 256 | 0.280 |
Why?
|
| Kidney Neoplasms | 2 | 2023 | 200 | 0.270 |
Why?
|
| Anxiety | 3 | 2024 | 190 | 0.260 |
Why?
|
| Communication | 3 | 2023 | 128 | 0.230 |
Why?
|
| Behavior | 2 | 2015 | 29 | 0.230 |
Why?
|
| Behavioral Medicine | 2 | 2016 | 6 | 0.220 |
Why?
|
| Attitude | 1 | 2005 | 37 | 0.220 |
Why?
|
| Clinical Trials, Phase III as Topic | 2 | 2022 | 27 | 0.220 |
Why?
|
| Cohort Studies | 5 | 2024 | 1840 | 0.220 |
Why?
|
| Interpersonal Relations | 2 | 2015 | 56 | 0.210 |
Why?
|
| Cancer Care Facilities | 2 | 2017 | 10 | 0.210 |
Why?
|
| Financing, Government | 1 | 2024 | 11 | 0.210 |
Why?
|
| Health Facilities | 1 | 2024 | 14 | 0.210 |
Why?
|
| Research Support as Topic | 1 | 2024 | 32 | 0.200 |
Why?
|
| Empirical Research | 1 | 2023 | 6 | 0.200 |
Why?
|
| Social Conditions | 1 | 2022 | 3 | 0.190 |
Why?
|
| Minority Groups | 1 | 2023 | 81 | 0.190 |
Why?
|
| Prevalence | 3 | 2015 | 955 | 0.190 |
Why?
|
| Registries | 2 | 2017 | 294 | 0.180 |
Why?
|
| Sarcoma | 1 | 2023 | 92 | 0.180 |
Why?
|
| Patient-Centered Care | 1 | 2022 | 75 | 0.170 |
Why?
|
| Religion | 3 | 2016 | 28 | 0.170 |
Why?
|
| Health Expenditures | 1 | 2021 | 66 | 0.170 |
Why?
|
| Decision Making | 1 | 2023 | 189 | 0.170 |
Why?
|
| Program Evaluation | 1 | 2021 | 171 | 0.170 |
Why?
|
| Motivation | 1 | 2021 | 120 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 180 | 0.160 |
Why?
|
| Meditation | 1 | 2020 | 27 | 0.150 |
Why?
|
| Social Change | 1 | 2019 | 2 | 0.150 |
Why?
|
| Treatment Outcome | 3 | 2016 | 3416 | 0.150 |
Why?
|
| Psychotherapy | 1 | 2019 | 19 | 0.150 |
Why?
|
| Calibration | 1 | 2019 | 24 | 0.150 |
Why?
|
| Focus Groups | 1 | 2019 | 123 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 106 | 0.140 |
Why?
|
| Comprehension | 1 | 2018 | 19 | 0.140 |
Why?
|
| Qualitative Research | 1 | 2019 | 179 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2017 | 368 | 0.130 |
Why?
|
| Electronic Health Records | 2 | 2017 | 179 | 0.130 |
Why?
|
| Health Behavior | 3 | 2009 | 211 | 0.130 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 20 | 0.130 |
Why?
|
| Chicago | 1 | 2016 | 10 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 2240 | 0.120 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 48 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 60 | 0.120 |
Why?
|
| Dementia | 1 | 2019 | 246 | 0.120 |
Why?
|
| Hypertension | 1 | 2023 | 979 | 0.120 |
Why?
|
| Affect | 2 | 2013 | 70 | 0.120 |
Why?
|
| Fertility | 1 | 2016 | 24 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 38 | 0.120 |
Why?
|
| Documentation | 1 | 2016 | 39 | 0.120 |
Why?
|
| Spiritual Therapies | 1 | 2015 | 2 | 0.120 |
Why?
|
| Indoles | 1 | 2016 | 65 | 0.120 |
Why?
|
| Students | 2 | 2009 | 174 | 0.110 |
Why?
|
| Pyrroles | 1 | 2016 | 59 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2016 | 86 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 1158 | 0.110 |
Why?
|
| Pyrimidines | 1 | 2016 | 77 | 0.110 |
Why?
|
| Prognosis | 1 | 2019 | 1534 | 0.110 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2015 | 37 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 853 | 0.110 |
Why?
|
| Appetite Stimulants | 1 | 2014 | 1 | 0.110 |
Why?
|
| Receptors, Ghrelin | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hydrazines | 1 | 2014 | 4 | 0.110 |
Why?
|
| Palliative Care | 1 | 2015 | 51 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2016 | 456 | 0.110 |
Why?
|
| Placebos | 1 | 2014 | 68 | 0.110 |
Why?
|
| Appetite | 1 | 2014 | 23 | 0.110 |
Why?
|
| Oligopeptides | 1 | 2014 | 49 | 0.110 |
Why?
|
| Whole-Body Irradiation | 1 | 2015 | 58 | 0.110 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 113 | 0.110 |
Why?
|
| Patient Care Planning | 1 | 2015 | 55 | 0.110 |
Why?
|
| Primary Health Care | 1 | 2017 | 232 | 0.110 |
Why?
|
| Hand Strength | 1 | 2014 | 98 | 0.110 |
Why?
|
| Sex Factors | 1 | 2016 | 657 | 0.100 |
Why?
|
| Sickness Impact Profile | 2 | 2011 | 39 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2023 | 3628 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2015 | 1233 | 0.100 |
Why?
|
| Employment | 1 | 2013 | 44 | 0.100 |
Why?
|
| Regression Analysis | 2 | 2014 | 273 | 0.090 |
Why?
|
| Risk Factors | 4 | 2023 | 3934 | 0.090 |
Why?
|
| Mood Disorders | 1 | 2012 | 20 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2014 | 2316 | 0.090 |
Why?
|
| Educational Status | 1 | 2013 | 167 | 0.090 |
Why?
|
| Antiemetics | 1 | 2012 | 5 | 0.090 |
Why?
|
| Pediatrics | 1 | 2013 | 158 | 0.090 |
Why?
|
| Social Desirability | 2 | 2009 | 12 | 0.090 |
Why?
|
| Psychotherapy, Brief | 1 | 2011 | 5 | 0.090 |
Why?
|
| Weight Loss | 1 | 2014 | 410 | 0.090 |
Why?
|
| Cost of Illness | 1 | 2011 | 72 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2023 | 854 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2020 | 553 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 183 | 0.080 |
Why?
|
| Kentucky | 1 | 2009 | 15 | 0.070 |
Why?
|
| Universities | 1 | 2009 | 149 | 0.070 |
Why?
|
| Psychological Theory | 1 | 2007 | 6 | 0.060 |
Why?
|
| Sexual Behavior | 2 | 2023 | 130 | 0.060 |
Why?
|
| Parents | 2 | 2021 | 151 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2006 | 393 | 0.060 |
Why?
|
| Information Systems | 2 | 2015 | 9 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2018 | 757 | 0.050 |
Why?
|
| Endosonography | 1 | 2004 | 55 | 0.050 |
Why?
|
| Vagina | 1 | 2004 | 61 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 37 | 0.050 |
Why?
|
| Gender Identity | 1 | 2023 | 28 | 0.050 |
Why?
|
| Bisexuality | 1 | 2023 | 32 | 0.050 |
Why?
|
| Data Collection | 1 | 2024 | 171 | 0.050 |
Why?
|
| Social Class | 1 | 2023 | 90 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 113 | 0.050 |
Why?
|
| Spouses | 1 | 2022 | 13 | 0.050 |
Why?
|
| Sexual Partners | 1 | 2022 | 38 | 0.050 |
Why?
|
| Substance-Related Disorders | 2 | 2016 | 140 | 0.040 |
Why?
|
| Genomics | 1 | 2022 | 89 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 167 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 264 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 45 | 0.040 |
Why?
|
| Age Factors | 2 | 2015 | 1179 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2020 | 34 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2023 | 417 | 0.040 |
Why?
|
| Education, Distance | 1 | 2019 | 18 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 129 | 0.040 |
Why?
|
| Exercise | 1 | 2021 | 603 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 222 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2017 | 137 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 54 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2015 | 23 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 11 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 20 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 18 | 0.030 |
Why?
|
| Internet | 1 | 2016 | 202 | 0.030 |
Why?
|
| American Cancer Society | 1 | 2015 | 3 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 324 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2015 | 83 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 48 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 97 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 78 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 238 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2015 | 202 | 0.030 |
Why?
|
| SEER Program | 1 | 2014 | 38 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 108 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 140 | 0.030 |
Why?
|
| Happiness | 1 | 2013 | 3 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 315 | 0.030 |
Why?
|
| Macrophages | 1 | 2015 | 207 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 499 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 542 | 0.020 |
Why?
|
| Pain | 1 | 2014 | 304 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1241 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 194 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 471 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 101 | 0.020 |
Why?
|
| CA-125 Antigen | 1 | 2006 | 8 | 0.020 |
Why?
|
| Ovary | 1 | 2006 | 66 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 155 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 86 | 0.010 |
Why?
|
| Mastectomy | 1 | 2005 | 59 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 194 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2005 | 84 | 0.010 |
Why?
|
| Elder Abuse | 1 | 2004 | 1 | 0.010 |
Why?
|
| Defense Mechanisms | 1 | 2004 | 4 | 0.010 |
Why?
|
| Sick Role | 1 | 2004 | 7 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2006 | 138 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 187 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2004 | 57 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 461 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 8199 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 883 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 1425 | 0.010 |
Why?
|